Legend Biotech Corporation

Somerset, United States

Legend Biotech Corporation is a biotechnology company focused on developing and manufacturing innovative therapies for patients with cancer and other serious diseases. The company is particularly known for its work in cell therapy, which involves modifying a patient's own cells to fight diseases more effectively. With a strong pipeline of products and ongoing clinical trials, Legend Biotech is positioning itself as a key player in the biopharmaceutical industry.

CCI Score

1.18

April 18

Latest Event

Legend Biotech Lobbying Activity Profile

Legend Biotech's lobbying profile, as compiled by OpenSecrets, reveals the company's engagement in political lobbying during the 2024 cycle. Data downloaded on February 19, 2025, reflects the firm's use of multiple lobbying firms to influence federal policy, raising concerns about corporate influence over public decision-making.

Take Action

So what can you do? Support Legend Biotech by shopping, spreading the word, or offering your support.

Shop Alternatives SEE ALL: Argenx

Verona Pharma

Rocket Pharma
Use Your Voice OTHER TOOLS
Investigate
Share the Score SUPPORT CCI

OBJECTOR

Legend Biotech Corporation is currently rated as an Objector.

0 to +9 CCI Score

These companies deliberately avoid direct involvement with authoritarian practices. While they do not actively challenge oppressive regimes, they maintain a neutral stance to ensure they are not complicit in supporting such systems.

Latest Events

FEB

19

2025

Legend Biotech Lobbying Activity Profile
-39.36

Legend Biotech's lobbying profile, as compiled by OpenSecrets, reveals the company's engagement in political lobbying during the 2024 cycle. Data downloaded on February 19, 2025, reflects the firm's use of multiple lobbying firms to influence federal policy, raising concerns about corporate influence over public decision-making.
-40

Political Contributions and Lobbying Efforts

April 15

The published lobbying profile indicates that Legend Biotech is actively engaging in political lobbying. Such behavior raises red flags from an anti-fascist perspective by suggesting that the company is investing in influencing policy to favor corporate interests over transparent democratic processes. This type of political contributions and lobbying effort can undermine accountability and may protect systems that marginalize ordinary citizens.

Legend Biotech Lobbying Profile
DEC

31

2024

Legend Biotech Lobbying Disclosure Q4 2024
-38.83

Legend Biotech Corporation disclosed a $100,000 lobbying activity during Q4 2024 aimed at educating Congress on the importance of biotechnology in healthcare, highlighting the company’s active engagement in shaping public policy in favor of corporate interests.
-40

Political Contributions and Lobbying Efforts

April 15

The disclosure of $100,000 in lobbying funds signals an effort by Legend Biotech to influence legislative priorities. While lobbying is a legal practice, from an anti-fascist perspective this reflects a concerning corporate strategy to shape policy decisions in a way that may prioritize private interests over democratic accountability and public welfare.

Lobbying Update: $100,000 of LEGEND BIOTECH CORPORATION lobbying was just disclosed
MAR

19

2024

Legend Biotech Publishes Inaugural ESG Report
31.41

Legend Biotech released its first Environmental, Social & Governance (ESG) report outlining its commitment to transparency, ethical business practices, and employee as well as community engagement. The report details initiatives such as responsible R&D investment, positive labor practices evidenced by an 85% employee engagement survey, and a robust framework for operational integrity.
+35

Business Practices and Ethical Responsibility

April 15

The release of the inaugural ESG report by Legend Biotech is a positive step from a progressive standpoint. The report demonstrates a commitment to ethical business practices including transparency, employee well-being, and community engagement. By publicly outlining its ESG initiatives, the company reinforces its dedication to social responsibility, aligning with anti-fascist values that prioritize accountability and fair treatment of stakeholders.

Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report
JAN

01

2024

Legend Biotech Lobbying Expenditure in 2024
-17.57

Legend Biotech reportedly spent $120,000 on lobbying efforts in 2024, as detailed in the OpenSecrets report. The expenditure highlights the firm's engagement in corporate political activity aimed at influencing U.S. policy.
-20

Political Contributions and Lobbying Efforts

April 15

The reported $120,000 lobbying expenditure indicates Legend Biotech’s active engagement in influencing political processes. From an anti-fascist perspective, such efforts can undermine democratic accountability and transparency, even if the amount is moderate. The use of corporate resources for lobbying, without clear evidence of promoting progressive or marginalized interests, is assessed negatively in the context of corporate political behavior.

Legend Biotech Lobbying Reports
JAN

01

2024

Legend Biotech Releases Sustainability Report 2024
70.27

Legend Biotech published its inaugural sustainability report outlining significant advancements in ESG initiatives, including enhanced governance structures, improved employee health and safety standards, expanded access to medicines, and better benefits for its workforce.
+80

Labor Relations and Human Rights Practices

April 15

The sustainability report demonstrates a strong commitment to ethical business practices by bolstering governance, prioritizing worker well-being with comprehensive health and safety metrics, and expanding access to medicine. These actions support progressive values and the protection of marginalized communities, strengthening labor relations and human rights practices.

Sustainability